尿道 Bulkamid® 注射治疗失败的尿道中段吊带术后：分步视频。
Urethral Bulkamid® injection after failed midurethral sling: a step-by-step video.
机构信息
Department of Gynecology, Division of Gynecology and Obstetrics, University Medical Center Ljubljana, Ljubljana, Slovenia.
Department of Gynecology and Obstetrics, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
出版信息
Int Urogynecol J. 2023 Nov;34(11):2843-2845. doi: 10.1007/s00192-023-05608-z. Epub 2023 Jul 29.
INTRODUCTION AND HYPOTHESIS
Bulking agents are a minimally invasive treatment option for women with stress urinary incontinence (SUI) or stress-predominant mixed urinary incontinence (MUI). Recurrent SUI is a major challenge for most clinicians because there is little evidence in the literature on the best option after midurethral sling (MUS) failure.
METHODS
Bulkamid® (Contura International A/S), a urethral bulking agent, is a homogenous gel without particles, consisting of a polyacrylamide hydrogel that is nonbiodegradable.
RESULTS
In this video case report, we demonstrate the Bulkamid® injection procedure. This procedure can be carried out as an office-based procedure under local anesthesia, with no down time and only minor possible complications.
CONCLUSIONS
We consider it a valid option for patients with recurrent or persistent SUI after failed MUS surgery.
简介和假设
对于压力性尿失禁（SUI）或以压力为主的混合性尿失禁（MUI）女性，膨体剂是一种微创治疗选择。大多数临床医生认为复发性 SUI 是一个主要挑战，因为在中尿道吊带（MUS）失败后，文献中几乎没有关于最佳选择的证据。
方法
Bulkamid®（Contura International A/S）是一种尿道膨体剂，是一种无颗粒的均匀凝胶，由不可生物降解的聚丙烯酰胺水凝胶组成。
结果
在这个视频病例报告中，我们展示了 Bulkamid®注射程序。该程序可以在局麻下作为门诊手术进行，无需停机时间，只有轻微的可能并发症。
结论
我们认为对于 MUS 手术后复发或持续性 SUI 的患者，这是一种有效的选择。
Zotero 插件